Prognostic value of peritoneal cancer index in primary advanced ovarian cancer

被引:80
作者
Llueca, Antoni [1 ,3 ,4 ]
Escrig, Javier [2 ,3 ,4 ]
机构
[1] Univ Gen Hosp Castellon, Dept Obstet & Gynecol, Castellon de La Plana, Spain
[2] Univ Gen Hosp Castellon, Dept Gen Surg, Castellon de La Plana, Spain
[3] Univ Gen Hosp Castellon, MUAPOS, Castellon de La Plana, Spain
[4] UJI, Dept Med, Castellon de La Plana, Spain
来源
EJSO | 2018年 / 44卷 / 01期
关键词
Advanced ovarian cancer; Debulking surgery; Peritoneal cancer index; Prognosis; Residual tumor; Survival; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; PRIMARY DEBULKING; RESIDUAL DISEASE; SURVIVAL; CARCINOMATOSIS; COMPLICATIONS; ORIGIN; IMPACT;
D O I
10.1016/j.ejso.2017.11.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Effective tumor debulking is a major factor associated with a favorable prognosis in patients with advanced ovarian cancer (AOC). However, FIGO staging fails to take full account of the extent of the disease in the peritoneum, making it difficult to plan appropriate surgical treatment. In contrast, the peritoneal cancer index (PCI) can provide more detailed information about peritoneal spread. Method: We evaluated the prognostic value of PCI and its association with clinicopathological features in patients with AOC. Data for 80 patients with AOC who underwent primary debulking surgery were analyzed retrospectively. PCI scores of 0-39 were calculated based on the sizes of lesions in 13 abdominopelvic regions, and patients were classified into three categories with scores of 1-10, 11-20, and >20, respectively. Clinicopathological features, including the presence of residual tumor after surgery and the incidence of postoperative complications, were assessed in relation to PCI score. Results: PCI was significantly associated with suboptimal surgery and postoperative complications, as well as with preoperative CA125, ascites, prolonged surgery, FIGO stage, positive aortic lymph nodes, prolonged hospitalization, and number of visceral resections. Overall and disease-free survival was also associated with PCI, with an optimal cut-off value of 15. Multivariate analysis identified age, residual tumor, and PCI as independent prognostic factors for survival. A PCI >10 is positively associated with a poor prognosis in patients with AOC. Conclusion: Given the importance of effective tumor debulking, PCI may provide important information for surgical planning in patients with AOC. (C) 2017 Elsevier Ltd, BASO - The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 26 条
[1]   Incidence and Impact of Lymph Node Metastases in Advanced Ovarian Cancer: Implications for Surgical Treatment [J].
Bachmann, Cornelia ;
Bachmann, Robert ;
Fend, Falko ;
Wallwiener, Diethelm .
JOURNAL OF CANCER, 2016, 7 (15) :2241-2246
[2]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[3]   Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer [J].
Cascales Campos, P. ;
Gil, Jose ;
Parrilla, Pascual .
EJSO, 2014, 40 (08) :970-975
[4]   Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm [J].
Chi, Dennis S. ;
Eisenhauer, Eric L. ;
Zivanovic, Oliver ;
Sonoda, Yukio ;
Abu-Rustum, Nadeem R. ;
Levine, Douglas A. ;
Guile, Matthew W. ;
Bristow, Robert E. ;
Aghajanian, Carol ;
Barakat, Richard R. .
GYNECOLOGIC ONCOLOGY, 2009, 114 (01) :26-31
[5]  
CLAVIEN PA, 1992, SURGERY, V111, P518
[6]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[7]   Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study [J].
Eisenkop, SM ;
Spirtos, NM ;
Friedman, RL ;
Lin, WCM ;
Pisani, AL ;
Perticucci, S .
GYNECOLOGIC ONCOLOGY, 2003, 90 (02) :390-396
[8]   Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery [J].
Eoh, Kyung Jin ;
Lee, Jung-Yun ;
Yoon, Jung Won ;
Nam, Eun Ji ;
Kim, Sunghoon ;
Kim, Sang-Wun ;
Kim, Young Tae .
ONCOTARGET, 2017, 8 (23) :37807-37816
[9]   Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement [J].
Esquivel, J. ;
Sticca, R. ;
Sugarbaker, P. ;
Levine, E. ;
Yan, T. D. ;
Alexander, R. ;
Baratti, D. ;
Bartlett, D. ;
Barone, R. ;
Barrios, P. ;
Bieligk, S. ;
Bretcha-Boix, P. ;
Chang, C. K. ;
Chu, F. ;
Chu, Q. ;
Daniel, S. ;
deBree, E. ;
Deraco, M. ;
Dominguez-Parra, L. ;
Elias, D. ;
Flynn, R. ;
Foster, J. ;
Garofalo, A. ;
Gilly, F. N. ;
Glehen, O. ;
Gomez-Portilla, A. ;
Gonzalez-Bayon, L. ;
Gonzalez-Moreno, S. ;
Goodman, M. ;
Gushchin, V. ;
Hanna, N. ;
Hartmann, J. ;
Harrison, L. ;
Hoefer, R. ;
Kane, J. ;
Kecmanovic, D. ;
Kelley, S. ;
Kuhn, J. ;
LaMont, J. ;
Lange, J. ;
Li, B. ;
Loggie, B. ;
Mahteme, H. ;
Mann, G. ;
Martin, R. ;
Misih, R. A. ;
Moran, B. ;
Morris, D. ;
Onate-Ocana, L. ;
Petrelli, N. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) :128-133
[10]   Toward Curative Treatment of Peritoneal Carcinomatosis From Nonovarian Origin by Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy A Multi-Institutional Study of 1290 Patients [J].
Glehen, Olivier ;
Gilly, Francois N. ;
Boutitie, Florent ;
Bereder, Jean M. ;
Quenet, Francois ;
Sideris, Lucas ;
Mansvelt, Baudouin ;
Lorimier, Gerard ;
Msika, Simon ;
Elias, Dominique .
CANCER, 2010, 116 (24) :5608-5618